| AASLD

p21‐activated kinase 4 inhibition protects against liver ischemia/reperfusion injury: Role of nuclear factor erythroid 2‐related factor 2 phosphorylation

Read more about p21‐activated kinase 4 inhibition protects against liver ischemia/reperfusion injury: Role of nuclear factor erythroid 2‐related factor 2 phosphorylation

Yuancheng Mao, Chang Yeob Han, Lihua Hao, Younho Lee, Jung Beom Son, Hwangeun Choi, Mi Rin Lee, Jae Do Yang, Suk Kyun Hong, Kyung‐Suk Suh, Hee Chul Yu, Nam Doo Kim, Eun Ju Bae, Byung‐Hyun Park – 1 February 2022

Mending the Model for End‐Stage Liver Disease: An in‐depth review of the past, present, and future portopulmonary hypertension Model for End‐Stage Liver Disease exception

Read more about Mending the Model for End‐Stage Liver Disease: An in‐depth review of the past, present, and future portopulmonary hypertension Model for End‐Stage Liver Disease exception

Hilary M. DuBrock, Kathryn T. Valle, Michael J. Krowka – 1 February 2022 – Patients with portopulmonary hypertension (POPH) have an increased cardiovascular and overall mortality risk when undergoing liver transplantation (LT). However, such risk is not captured in their Model for End‐Stage Liver Disease (MELD) laboratory score. POPH MELD exception criteria were established in 2006 with the aim of prioritizing these patients for LT prior to pulmonary hypertension (PH) progression and eventual right heart failure.

Reply

Read more about Reply

Victor H. F. Lee, Tiffany C. L. Wong – 1 February 2022

Tumor‐derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression

Read more about Tumor‐derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression

Chubin Luo, Haoyang Xin, Zhengjun Zhou, Zhiqiang Hu, Rongqi Sun, Na Yao, Qiman Sun, Uyunbilig Borjigin, Xia Wu, Jia Fan, Xiaowu Huang, Shaolai Zhou, Jian Zhou – 1 February 2022

AASLD Practice Guidance: Palliative care and symptom‐based management in decompensated cirrhosis

Read more about AASLD Practice Guidance: Palliative care and symptom‐based management in decompensated cirrhosis

Shari S. Rogal, Lissi Hansen, Arpan Patel, Nneka N. Ufere, Manisha Verma, Christopher D. Woodrell, Fasiha Kanwal – 31 January 2022

Letter to the editor: Spontaneous regression of cirrhosis: A paradigm shift in our understanding of the natural history of NASH

Read more about Letter to the editor: Spontaneous regression of cirrhosis: A paradigm shift in our understanding of the natural history of NASH

Arka De, Amarjit Keisham, Ajay Duseja – 30 January 2022

Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis

Read more about Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis

Heejoon Jang, Yun Bin Lee, Hyemi Moon, Jong‐Won Chung, Joon Yeul Nam, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Juneyoung Lee, Jung‐Hwan Yoon – 30 January 2022

Discovery of an insulin‐induced gene binding compound that ameliorates nonalcoholic steatohepatitis by inhibiting sterol regulatory element‐binding protein–mediated lipogenesis

Read more about Discovery of an insulin‐induced gene binding compound that ameliorates nonalcoholic steatohepatitis by inhibiting sterol regulatory element‐binding protein–mediated lipogenesis

Shi‐You Jiang, Xinglin Yang, Zimo Yang, Jue‐Wan Li, Meng‐Qiang Xu, Yu‐Xiu Qu, Jing‐Jie Tang, Yun‐Feng Li, Liguo Wang, Yi‐Wen Shao, Xin‐Yuan Meng, Huili Hu, Bao‐Liang Song, Yu Rao, Wei Qi – 30 January 2022

Reply

Read more about Reply

Ya Deng, Chun‐Yan Wang, Xiao‐Xia Niu, Dong Ji – 30 January 2022

Cerium oxide nanoparticles administration during machine perfusion of discarded human livers: A pilot study

Read more about Cerium oxide nanoparticles administration during machine perfusion of discarded human livers: A pilot study

Serena Del Turco, Valentina Cappello, Christos Tapeinos, Aldo Moscardini, Laura Sabatino, Matteo Battaglini, Fabio Melandro, Francesco Torri, Caterina Martinelli, Serena Babboni, Beatrice Silvestrini, Riccardo Morganti, Mauro Gemmi, Paolo De Simone, Paulo N. Martins, Laura Crocetti, Adriano Peris, Daniela Campani, Giuseppina Basta, Gianni Ciofani, Davide Ghinolfi – 30 January 2022 – The combined approach of ex situ normothermic machine perfusion (NMP) and nanotechnology represents a strategy to mitigate ischemia/reperfusion injury in liver transplantation (LT).

Subscribe to